235 related articles for article (PubMed ID: 20695833)
21. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
22. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
Takami T; Murakami Y
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147
[TBL] [Abstract][Full Text] [Related]
23. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
24. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.
Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y
Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922
[TBL] [Abstract][Full Text] [Related]
25. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
[TBL] [Abstract][Full Text] [Related]
26. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release.
Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
J Microencapsul; 2005 Sep; 22(6):671-82. PubMed ID: 16401582
[TBL] [Abstract][Full Text] [Related]
27. Encapsulation of azithromycin into polymeric microspheres by reduced pressure-solvent evaporation method.
Li X; Chang S; Du G; Li Y; Gong J; Yang M; Wei Z
Int J Pharm; 2012 Aug; 433(1-2):79-88. PubMed ID: 22583850
[TBL] [Abstract][Full Text] [Related]
28. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
Ahmed AR; Bodmeier R
Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
[TBL] [Abstract][Full Text] [Related]
29. In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters.
Luan X; Bodmeier R
Eur J Pharm Sci; 2006 Feb; 27(2-3):143-9. PubMed ID: 16243496
[TBL] [Abstract][Full Text] [Related]
30. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles.
Jaraswekin S; Prakongpan S; Bodmeier R
J Microencapsul; 2007 Mar; 24(2):117-28. PubMed ID: 17454423
[TBL] [Abstract][Full Text] [Related]
31. Doxycycline delivery from PLGA microspheres prepared by a modified solvent removal method.
Patel RS; Cho DY; Tian C; Chang A; Estrellas KM; Lavin D; Furtado S; Mathiowitz E
J Microencapsul; 2012; 29(4):344-52. PubMed ID: 22263669
[TBL] [Abstract][Full Text] [Related]
32. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
34. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
35. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV; Couet W; Olivier JC
Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
[TBL] [Abstract][Full Text] [Related]
36. Rupture and drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
Matsumoto A; Matsukawa Y; Horikiri Y; Suzuki T
Int J Pharm; 2006 Dec; 327(1-2):110-6. PubMed ID: 16971073
[TBL] [Abstract][Full Text] [Related]
37. Stability Evaluation of Ivermectin-Loaded Biodegradable Microspheres.
Dorati R; Genta I; Colzani B; Modena T; Bruni G; Tripodo G; Conti B
AAPS PharmSciTech; 2015 Oct; 16(5):1129-39. PubMed ID: 25700978
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation.
Giovagnoli S; Blasi P; Ricci M; Schoubben A; Perioli L; Rossi C
J Pharm Sci; 2008 Jan; 97(1):303-17. PubMed ID: 17721943
[TBL] [Abstract][Full Text] [Related]
39. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
[TBL] [Abstract][Full Text] [Related]
40. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
